DUBLIN--(BUSINESS WIRE)--Jan. 5, 2016--
Alkermes
plc (NASDAQ: ALKS) announced today that its corporate presentation
will be webcast live at the 34th Annual J.P. Morgan
Healthcare Conference on Tuesday, Jan. 12, 2016, at 9:00 a.m. PST (12:00
p.m. EST/5:00 p.m. GMT) from the Westin St. Francis Hotel in San
Francisco. The presentation will be followed by a question and answer
session that will begin at 9:30 a.m. PST (12:30 p.m. EST/5:30 p.m. GMT).
A webcast of both the presentation and question and answer session may
be accessed under the Investors tab on www.alkermes.com
and will be archived for 14 days.
Alkermes plc is a fully integrated, global biopharmaceutical company
developing innovative medicines for the treatment of central nervous
system (CNS) diseases. The company has a diversified commercial product
portfolio and a substantial clinical pipeline of product candidates for
chronic diseases that include schizophrenia, depression, addiction and
multiple sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has
an R&D center in Waltham, Massachusetts; a research and manufacturing
facility in Athlone, Ireland; and a manufacturing facility in
Wilmington, Ohio. For more information, please visit Alkermes’ website
at www.alkermes.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160105006622/en/
Source: Alkermes plc
Alkermes plc
Eva Stroynowski, +1 781 609 6823
Corporate
Communications
